Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P01 ANTIPROTOZOALS
P01B ANTIMALARIALS
P01BC Methanolquinolines
P01BC02 Mefloquine
D00831 Mefloquine hydrochloride (JP18/USP) <JP/US>
USP drug classification [BR:br08302]
Antiparasitics
Antiprotozoals
Mefloquine
D00831 Mefloquine hydrochloride (JP18/USP)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
64 Parasitics (systemic)
641 Antiprotozoans
6419 Others
D00831 Mefloquine hydrochloride (JP18/USP)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG01020 Mefloquine
D00831 Mefloquine hydrochloride
Antimicrobials [BR:br08307]
Antiparasitics
Antmalarials
Methanolquinoline
D00831 Mefloquine hydrochloride (JP18/USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00831 Mefloquine hydrochloride
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00831
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00831
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG01020 Mefloquine